Ann: US FDA Feedback on Type C Meeting for ATL1102 in the US, page-139

Strange report..25 c-27c valuations..Important things to remember is that MD has said in the last presentation that the market is not even valueing ANP on the current achievements forget about the news flow/progress that is in the pipeline..

Also, we have been told to stay patient. CR or not at 20c or 40 c ( I seriously think it would be at or over 40c). I also remember that the last time CR was done, the SP doubled in the next few weeks.. Let's see what MD comes out with..As I said yesterday, he needs to show the Bank balance for the EMA approvals....

@Uboy nondilutive funding has been mentioned for a reason. Do we really think that MD has funding left for the last minute? I don't think so..

All is planned to perfection, we just wait..

Also, the chart is looking good to take out 22c tomorrow..

IMO/DYOR